Nu Skin Enterprises, Inc.
NUS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,732,084 | $1,969,131 | $2,225,659 | $2,695,669 |
| % Growth | -12% | -11.5% | -17.4% | – |
| Cost of Goods Sold | $550,233 | $611,850 | $630,915 | $675,223 |
| Gross Profit | $1,181,851 | $1,357,281 | $1,594,744 | $2,020,446 |
| % Margin | 68.2% | 68.9% | 71.7% | 75% |
| R&D Expenses | $13,000 | $22,600 | $0 | $27,200 |
| G&A Expenses | $479,037 | $546,858 | $555,769 | $666,395 |
| SG&A Expenses | $1,131,076 | $1,289,223 | $1,435,403 | $1,734,584 |
| Sales & Mktg Exp. | $652,039 | $742,365 | $879,634 | $1,068,189 |
| Other Operating Expenses | $189,360 | -$2,810 | $48,494 | $24,670 |
| Operating Expenses | $1,333,436 | $1,309,013 | $1,483,897 | $1,786,454 |
| Operating Income | -$151,585 | $48,268 | $110,847 | $233,992 |
| % Margin | -8.8% | 2.5% | 5% | 8.7% |
| Other Income/Exp. Net | -$23,466 | -$21,690 | -$21,877 | -$1,533 |
| Pre-Tax Income | -$175,051 | $26,578 | $88,970 | $232,459 |
| Tax Expense | -$28,457 | $17,983 | -$15,808 | $85,193 |
| Net Income | -$146,594 | $8,595 | $104,778 | $147,266 |
| % Margin | -8.5% | 0.4% | 4.7% | 5.5% |
| EPS | -2.95 | 0.17 | 2.1 | 2.93 |
| % Growth | -1,835.3% | -91.9% | -28.3% | – |
| EPS Diluted | -2.95 | 0.17 | 2.07 | 2.86 |
| Weighted Avg Shares Out | 49,662 | 49,711 | 50,002 | 50,193 |
| Weighted Avg Shares Out Dil | 49,662 | 49,860 | 50,525 | 51,427 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $10,383 | $11,157 |
| Interest Expense | $26,409 | $25,560 | $21,877 | $11,000 |
| Depreciation & Amortization | $69,810 | $69,223 | $72,506 | $125,024 |
| EBITDA | -$78,832 | $202,981 | $174,969 | $368,483 |
| % Margin | -4.6% | 10.3% | 7.9% | 13.7% |